Zai Lab Ltd
ZLAB32.650USD
-0.350-1.06%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
3.59BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Zai Lab Ltd Unternehmen
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Unternehmensinformationen
BörsenkürzelZLAB
Name des UnternehmensZai Lab Ltd
IPO-datumSep 28, 2020
CEODr. Ying (Samantha) Du, Ph.D.
Anzahl der mitarbeiter1869
WertpapierartDepository Receipt
GeschäftsjahresendeSep 28
AddresseBuilding B, 899 Halei Road, Pudong
StadtSHANGHAI
BörseNASDAQ Global Market Consolidated
LandChina
Postleitzahl201203
Telefon862161632588
Websitehttps://www.zailaboratory.com/
BörsenkürzelZLAB
IPO-datumSep 28, 2020
CEODr. Ying (Samantha) Du, Ph.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Dr. Richard B. Gaynor, M.D.
Dr. Richard B. Gaynor, M.D.
Independent Director
Independent Director
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Ms. Christine Chiou
Ms. Christine Chiou
Senior Vice President, Head - Investor Relations
Senior Vice President, Head - Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+12.18%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+13.05%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-7.83%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
16.72K
-20.40%
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Michel Pericles Vounatsos
Mr. Michel Pericles Vounatsos
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Andere
3.03M
2.86%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
ZEJULA
49.53M
46.88%
VYVGART
18.11M
17.14%
NUZYRA
15.12M
14.31%
Optune
11.36M
10.76%
QINLOCK
8.51M
8.05%
Andere
3.03M
2.86%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Andere
79.72%
Aktionäre
Aktionäre
Anteil
Capital World Investors
5.40%
RTW Investments L.P.
4.95%
Fidelity Management & Research Company LLC
4.37%
ClearBridge Investments, LLC
3.59%
Janus Henderson Investors
1.97%
Andere
79.72%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
16.87%
Investment Advisor
16.18%
Hedge Fund
5.50%
Individual Investor
1.74%
Private Equity
1.38%
Venture Capital
1.13%
Research Firm
0.89%
Pension Fund
0.44%
Sovereign Wealth Fund
0.18%
Andere
55.69%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
2023Q4
497
46.31M
46.92%
-16.57M
2023Q3
537
44.27M
45.68%
-20.42M
2023Q2
568
47.21M
48.74%
-23.76M
2023Q1
572
60.29M
61.61%
-11.82M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Capital World Investors
6.01M
5.41%
-425.00K
-6.61%
Mar 31, 2025
RTW Investments L.P.
3.14M
2.82%
+627.56K
+25.01%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.68M
4.21%
+945.91K
+25.33%
Mar 31, 2025
ClearBridge Investments, LLC
3.28M
2.95%
+1.42M
+76.05%
Mar 31, 2025
Janus Henderson Investors
3.81M
3.43%
-2.75M
-41.94%
Mar 31, 2025
Baron Capital Management, Inc.
1.83M
1.65%
-79.59K
-4.17%
Mar 31, 2025
Segantii Capital Management Limited
1.56M
1.4%
-131.64K
-7.80%
Mar 31, 2024
Wellington Management Company, LLP
3.65M
3.28%
-3.01M
-45.22%
Mar 31, 2025
Fidelity Institutional Asset Management
1.70M
1.53%
-43.29K
-2.49%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
SPDR Portfolio MSCI Global Stock Market ETF
0%
Innovator IBD 50 Fund ETF
0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
National Security Emerging Markets Index ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
0%
DFA Dimensional Emerging Core Equity Market ETF
0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
0%
WisdomTree Emerging Markets Efficient Core Fund
0%
SPDR Portfolio MSCI Global Stock Market ETF
Anteil0%
Innovator IBD 50 Fund ETF
Anteil0%
SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
Anteil0%
ProShares Ultra Nasdaq Biotechnology
Anteil0%
National Security Emerging Markets Index ETF
Anteil0%
Invesco Nasdaq Biotechnology ETF
Anteil0%
Xtrackers Emg Mkt Carbon Reduction and Cl Imp ETF
Anteil0%
DFA Dimensional Emerging Core Equity Market ETF
Anteil0%
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
Anteil0%
WisdomTree Emerging Markets Efficient Core Fund
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
